sixty consecutive patients , 15-60 years old , with anll were divided randomly into three groups for induction treatment with one of the following regimens : r1 , daunorubicin ( dnr ) 1.5 mg/kg on day 1 + ara-c 2 mg/kg body weight on days 1-5 ;
C0023467
anll
C0011015
daunorubicin